Axiom Ventures

Axiom Venture Partners, L.P. is a venture capital firm established in 1994 and located in East Hartford, Connecticut. The firm specializes in investing in mid and late stage companies, primarily within the biotechnology and high technology sectors. Axiom focuses on areas such as communications, software, internet infrastructure, and information technology. The firm aims to make investments across the United States, supporting companies that show potential for growth and innovation in these fields.

Barry Bronfin

Partner

Samuel (Sam) Mckay

General Partner and Co-Founder

Past deals in Connecticut

Tangen Biosciences

Series A in 2019
Tangen Biosciences LLC develops medical instrument that provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction (PCR) amplification.

Melinta

Series D in 2009
Melinta Therapeutics, Inc. is a commercial-stage pharmaceutical company specializing in the discovery, development, and commercialization of anti-infective therapies targeting bacterial infections. The company offers several products, including Baxdela, Vabomere, Orbactiv, and Minocin, which address various acute bacterial skin infections and gram-negative infections. Recognizing the urgent need for new antibiotics to combat drug-resistant infections, Melinta is advancing delafloxacin, currently in Phase 3 development for treating acute bacterial skin and skin structure infections. The company also focuses on developing innovative antibiotics aimed at overcoming resistant pathogens associated with serious hospital infections. Established in 2000, Melinta Therapeutics is headquartered in Morristown, New Jersey, and operates with support from strategic partners in the healthcare sector.

Tangoe

Series E in 2006
Tangoe, a telecommunications group, provides software and technology-driven services that enable global organizations to procure, manage, and control their fixed, mobile, and converged communications assets and their costs. Global 2000 organizations and government agencies depend upon Tangoe solutions to more effectively manage their communications processes. Tangoe has offices in Orange, CT, Austin, TX, Hoboken, NJ, and Waltham, MA.

Melinta

Series C in 2006
Melinta Therapeutics, Inc. is a commercial-stage pharmaceutical company specializing in the discovery, development, and commercialization of anti-infective therapies targeting bacterial infections. The company offers several products, including Baxdela, Vabomere, Orbactiv, and Minocin, which address various acute bacterial skin infections and gram-negative infections. Recognizing the urgent need for new antibiotics to combat drug-resistant infections, Melinta is advancing delafloxacin, currently in Phase 3 development for treating acute bacterial skin and skin structure infections. The company also focuses on developing innovative antibiotics aimed at overcoming resistant pathogens associated with serious hospital infections. Established in 2000, Melinta Therapeutics is headquartered in Morristown, New Jersey, and operates with support from strategic partners in the healthcare sector.

Tangoe

Series D in 2006
Tangoe, a telecommunications group, provides software and technology-driven services that enable global organizations to procure, manage, and control their fixed, mobile, and converged communications assets and their costs. Global 2000 organizations and government agencies depend upon Tangoe solutions to more effectively manage their communications processes. Tangoe has offices in Orange, CT, Austin, TX, Hoboken, NJ, and Waltham, MA.

Paragon Networks International

Venture Round in 2001
Paragon Networks International is an innovative manufacturer of broadband digital integrated access and optical metro internetworking platforms. They are a leading provider of application specific service deployment and wide area network optimization solutions to wireless service providers (WSP) and network service providers (NSP) worldwide. Utilizing either wireline, wireless, or optical transmission facilities, their products provide voice and data service connectivity, performance monitoring, compression, aggregation, layer 3 routing, quality of service (QOS) filtering, and protection switching of both client and operations support systems (OSS) traffic. Their solutions deliver superior network performance and control at substantial cost savings to their clients.

Open Solutions

Venture Round in 2000
Open Solutions provides collaborative, enterprise core account processing technology for banks, thrifts and credit unions, along with a full range of surround solutions.